We also wish to thank Peter Ravn (MedImmune Ltd, Cambridge, UK) for intellectual input into GLP-1 analogue peptide stabilization, Bojana Popovic and Daniel Cannon (MedImmune Ltd, Cambridge, UK) for generating and analysing the peptide homology model, Adrian Podmore (MedImmune Ltd, Cambridge, UK) for conducting the aggregation and stability testing, Richard Kay (LGC, Fordham, UK) for conducting the mass spectrometry metabolites identification work, Marcella Petrone and John Hood (MedImmune Ltd, Cambridge, UK) for performing PK-PD simulations and analysis as well as Christopher Rhodes (MedImmune LLC, Gaithersburg, MD, USA) for his critical review of this manuscript
Lancet 378 , 412419 (2011)
Diabet Med 2012;29:12601267
Selank and Semax Originally developed as nootropic (cognitive-enhancing) peptides in humans, these are sometimes used in pets with cognitive decline or anxiety
More time in the stomach could mean theres a delay in drug absorption